Biomarker based standards and methods of use

Abstract

Provided herein are compositions and methods for fluorescence activated cell analysis of white blood cell populations. The compositions and methods enable thorough characterization each subpopulation of a greater cell population of leukocytes. Additionally, the biomarker-based standards and methods of are expedited as compared to the conventional technology and produce a positive control test material that reduces the cost, expedites the process, and improves the outcome of fluorescence activated cell analysis of blood cell populations.